Global Medical REIT Inc.
Symboli: GMRE
NYSE
9.03
USDMarkkinahinta tänään
30.7150
P/E-suhde
0.5877
PEG-suhde
592.14M
MRK Cap
- 0.09%
DIV Tuotto
Global Medical REIT Inc. (GMRE) Tilinpäätöstiedotteet
Tase
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 7.4 | 4 | 7.2 | |||||||||||||
balance-sheet.row.short-term-investments | 0 | 25.1 | 34.7 | 1.2 | |||||||||||||
balance-sheet.row.net-receivables | 0 | 33.7 | 8.2 | 6.2 | |||||||||||||
balance-sheet.row.inventory | 0 | -25.1 | -34.7 | -1.2 | |||||||||||||
balance-sheet.row.other-current-assets | 0 | -41.1 | 18.3 | -50.3 | |||||||||||||
balance-sheet.row.total-current-assets | 0 | 14.4 | 30.5 | 24.9 | |||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 7.6 | 3.5 | 3.8 | |||||||||||||
balance-sheet.row.goodwill | 0 | 5.9 | 5.9 | 5.9 | |||||||||||||
balance-sheet.row.intangible-assets | 0 | 66 | 148.1 | 127.9 | |||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 71.9 | 154 | 133.8 | |||||||||||||
balance-sheet.row.long-term-investments | 0 | 25.1 | 34.7 | 1.2 | |||||||||||||
balance-sheet.row.tax-assets | 0 | 1140.3 | -34.7 | -1.2 | |||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 8.5 | 1205.3 | 1100.9 | |||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 1253.3 | 1362.7 | 1238.5 | |||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||
balance-sheet.row.total-assets | 0 | 1267.7 | 1393.3 | 1263.5 | |||||||||||||
balance-sheet.row.account-payables | 0 | 12.8 | 13.8 | 10.3 | |||||||||||||
balance-sheet.row.short-term-debt | 0 | 0.4 | 636.4 | 514.6 | |||||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | |||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 610.8 | 57.7 | 57.2 | |||||||||||||
Deferred Revenue Non Current | 0 | 5.1 | 4.4 | 3.2 | |||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||||
balance-sheet.row.other-current-liab | 0 | 601.1 | 11.4 | 15.7 | |||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 42.5 | 78.1 | 85.3 | |||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 13 | 10.5 | 8.1 | |||||||||||||
balance-sheet.row.total-liab | 0 | 661.9 | 744.2 | 625.9 | |||||||||||||
balance-sheet.row.preferred-stock | 0 | 75 | 75 | 75 | |||||||||||||
balance-sheet.row.common-stock | 0 | 0.1 | 0.1 | 0.1 | |||||||||||||
balance-sheet.row.retained-earnings | 0 | -239 | -198.7 | -157 | |||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 25.1 | 34.7 | -6.6 | |||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 722.4 | 722 | 711.4 | |||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 583.6 | 633 | 622.8 | |||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 1267.7 | 1393.3 | 1263.5 | |||||||||||||
balance-sheet.row.minority-interest | 0 | 22.2 | 16.1 | 14.8 | |||||||||||||
balance-sheet.row.total-equity | 0 | 605.8 | 649.1 | 637.6 | |||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||||||
Total Investments | 0 | 25.1 | 34.7 | 1.2 | |||||||||||||
balance-sheet.row.total-debt | 0 | 624.2 | 694.1 | 571.7 | |||||||||||||
balance-sheet.row.net-debt | 0 | 616.8 | 690.1 | 564.5 |
Kassavirtalaskelma
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 20.6 | 20 | 18.3 | ||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 58.1 | 57.7 | 47.3 | ||||||||||||
cash-flows.row.deferred-income-tax | 0 | -122.1 | 0 | -0.9 | ||||||||||||
cash-flows.row.stock-based-compensation | 0 | 4.2 | 4.7 | 5.8 | ||||||||||||
cash-flows.row.change-in-working-capital | 0 | -5.7 | -1.7 | -3.8 | ||||||||||||
cash-flows.row.account-receivables | 0 | 0.4 | -3 | -0.7 | ||||||||||||
cash-flows.row.inventory | 0 | 0 | 0 | 0.2 | ||||||||||||
cash-flows.row.account-payables | 0 | -2 | 4.1 | 1.9 | ||||||||||||
cash-flows.row.other-working-capital | 0 | -4.1 | -2.8 | -5.3 | ||||||||||||
cash-flows.row.other-non-cash-items | 0 | 113.3 | -4.1 | 2.2 | ||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -10 | -156.2 | -201.7 | ||||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 2 | 2.8 | ||||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | -2 | -2.8 | ||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 86.1 | 11.1 | 4.4 | ||||||||||||
cash-flows.row.other-investing-activites | 0 | -1.3 | 7.8 | 2.6 | ||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | 74.8 | -137.3 | -194.7 | ||||||||||||
cash-flows.row.debt-repayment | 0 | -86.1 | -16.7 | -232.2 | ||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 9.9 | 205.5 | ||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 221.6 | ||||||||||||
cash-flows.row.dividends-paid | 0 | -64.8 | -64.2 | -58.3 | ||||||||||||
cash-flows.row.other-financing-activites | 0 | 0 | 133.4 | -8.9 | ||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -150.9 | 62.4 | 127.7 | ||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | -77.5 | 0 | 0 | ||||||||||||
cash-flows.row.net-change-in-cash | 0 | -14.9 | 1.7 | 2 | ||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 7.4 | 14.5 | 12.8 | ||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 22.3 | 12.8 | 10.8 | ||||||||||||
cash-flows.row.operating-cash-flow | 0 | 68.4 | 76.5 | 69 | ||||||||||||
cash-flows.row.capital-expenditure | 0 | -10 | -156.2 | -201.7 | ||||||||||||
cash-flows.row.free-cash-flow | 0 | 58.4 | -79.7 | -132.7 |
Tuloslaskelmarivi
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 156.7 | 137.3 | 115.9 | ||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 86.2 | 25.2 | 15.5 | ||||||||||||
income-statement-row.row.gross-profit | 0 | 70.4 | 112.1 | 100.4 | ||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||
income-statement-row.row.other-expenses | 0 | -16.9 | 56.7 | 46.9 | ||||||||||||
income-statement-row.row.operating-expenses | 0 | 16.9 | 73.3 | 63.3 | ||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 103.1 | 98.5 | 78.8 | ||||||||||||
income-statement-row.row.interest-income | 0 | 0 | 25.2 | 19.7 | ||||||||||||
income-statement-row.row.interest-expense | 0 | 46.5 | 25.2 | 19.7 | ||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -31.8 | -18.8 | -18.8 | ||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||
income-statement-row.row.other-operating-expenses | 0 | -16.9 | 56.7 | 46.9 | ||||||||||||
income-statement-row.row.total-operating-expenses | 0 | -31.8 | -18.8 | -18.8 | ||||||||||||
income-statement-row.row.interest-expense | 0 | 46.5 | 25.2 | 19.7 | ||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 58.1 | 57.7 | 46.9 | ||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||||||
income-statement-row.row.operating-income | 0 | 53.5 | 38.8 | 37.1 | ||||||||||||
income-statement-row.row.income-before-tax | 0 | 21.7 | 20 | 18.3 | ||||||||||||
income-statement-row.row.income-tax-expense | 0 | 1.1 | 25.2 | 20.4 | ||||||||||||
income-statement-row.row.net-income | 0 | 20.6 | -5.2 | -2.1 |
Usein kysytty kysymys
Mikä on Global Medical REIT Inc. (GMRE) taseen loppusumma?
Global Medical REIT Inc. (GMRE) kokonaisvarat ovat 1267700000.000.
Mikä on yrityksen vuotuinen liikevaihto?
Vuotuinen liikevaihto on N/A.
Mikä on yrityksen voittomarginaali?
Yrityksen voittomarginaali on 0.759.
Mikä on yrityksen vapaa kassavirta?
Vapaa kassavirta on 0.891.
Mikä on yrityksen nettovoittomarginaali?
Nettovoittomarginaali on 0.134.
Mikä on yrityksen kokonaistulot?
Kokonaisliikevaihto on 0.345.
Mikä on Global Medical REIT Inc. (GMRE) nettovoitto (nettotulos)?
Nettovoitto (nettotulos) on 20612000.000.
Mikä on yrityksen kokonaisvelka?
Kokonaisvelka on 624193000.000.
Mikä on yrityksen toimintakulujen määrä?
Toimintakulut ovat 16897000.000.
Mikä on yrityksen kassan määrä?
Yrityksen kassavarat ovat 0.000.